Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

AIDS and HIV infection

C Smith¹, B A Sullenger

¹Genzyme Corporation, Framingham, Massachusetts 01701-9322, USA.

Molecular and Cell Biology of Human Diseases Series

|January 1, 1995

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Generation and characterization of aptamers targeting factor XIa.

Thrombosis research·2017

Same author

A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.

Journal of thrombosis and haemostasis : JTH·2017

Same author

Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.

Journal of thrombosis and haemostasis : JTH·2013

Same author

A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.

Journal of thrombosis and haemostasis : JTH·2012

Same author

Antidote control of aptamer therapeutics: the road to a safer class of drug agents.

Current pharmaceutical biotechnology·2012

Same author

Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers.

Oligonucleotides·2007